Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Allergy & Immunology
•
Immunosuppression
•
Anaphylaxis
•
Allergy
•
Immunology
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Patient with seropositive RA, immunodeficiency, and idiopathic anaphylaxis.
Related Questions
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Do you perform genetic testing when patients have persistent hypogammaglobulinemia after rituximab therapy?
How do you approach managing nausea and GI side effects when initiating methotrexate?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?